A third possibility is that heterozygous SOX9 mutations confer phenotypic plasticity, defined as the ability to change cell states, which is increasingly being recognized for its contributions to cancer initiation, progression, metastasis, and drug resistance.9 Here, SOX9 is linked to cancer.